FDA Import Refusal 799-5614430-8/11/2 — AstraZeneca Pharma India Limited
The FDA refused shipment 799-5614430-8/11/2 from AstraZeneca Pharma India Limited (India) on Feb 12, 2025. The refused product falls under Drugs and Biologics — MONTELUKAST SODIUM (ANTI-ASTHMATIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Feb 12, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61EDY09 MONTELUKAST SODIUM (ANTI-ASTHMATIC)
- Charges
- 75